Prudential Financial Inc Protalix Bio Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 36,400 shares of PLX stock, worth $91,728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,400Holding current value
$91,728% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
51Shares Held
3.47MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$2.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$941,8670.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$839,5900.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$770,4870.04% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$680,4000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $125M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...